Is CRM stock a good buy in 2022?

Then CRM stock retreated nearly 48% in 2022. According to IBD Stock Checkup, CRM stock currently has a Relative Strength Rating of 91 out of a best-possible 99. The best stocks tend to have ratings of 80 and above. Further, CRM stock holds an IBD Composite Rating of 98 out of a best possible 99.

What is the next quarter's sales forecast for CRM?

Next quarter’s sales forecast for CRM is $8.14B with a range of $6.97B to $8.38B. The previous quarter’s sales results were $8.38B. CRM beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 63.69% of the time in the same period.

Could CRM stock get a lift from federal information technology spending?

More companies are investing in business analytics and artificial intelligence tools that scrub customer data. In addition, CRM stock could get a lift from U.S. federal information technology spending. The company recently unveiled "no-code" programming tools for the public sector.

Should you buy Salesforce (CRM)?

41 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 1 sell rating, 12 hold ratings, 27 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CRM shares. View CRM analyst ratings or view top-rated stocks.